226 related articles for article (PubMed ID: 18606984)
41. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
[TBL] [Abstract][Full Text] [Related]
42. The influence of parental age and gender on anticipation in familial B-cell malignancies.
Alexandrescu DT; Wiernik PH
Med Oncol; 2007; 24(1):55-62. PubMed ID: 17673812
[TBL] [Abstract][Full Text] [Related]
43. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden.
Kristinsson SY; Björkholm M; Goldin LR; McMaster ML; Turesson I; Landgren O
Blood; 2008 Oct; 112(8):3052-6. PubMed ID: 18703425
[TBL] [Abstract][Full Text] [Related]
44. [Inheritance in lymphoproliferative disorders].
Jønsson V; Olsen JH
Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
[TBL] [Abstract][Full Text] [Related]
45. Trends in hematological cancer in the elderly in Denmark, 1980-2012.
Ocias LF; Larsen TS; Vestergaard H; Friis LS; Abildgaard N; Frederiksen H;
Acta Oncol; 2016; 55 Suppl 1():98-107. PubMed ID: 26783877
[TBL] [Abstract][Full Text] [Related]
46. Clonal relation in a case of CLL, ALCL, and Hodgkin composite lymphoma.
van den Berg A; Maggio E; Rust R; Kooistra K; Diepstra A; Poppema S
Blood; 2002 Aug; 100(4):1425-9. PubMed ID: 12149227
[TBL] [Abstract][Full Text] [Related]
47. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M
Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387
[TBL] [Abstract][Full Text] [Related]
48. Sex- and kindred-specific familial risk of non-Hodgkin's lymphoma.
Czene K; Adami HO; Chang ET
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2496-9. PubMed ID: 18006943
[TBL] [Abstract][Full Text] [Related]
49. Risk of second malignant neoplasms among lymphoma patients with a family history of cancer.
Landgren O; Pfeiffer RM; Stewart L; Gridley G; Mellemkjaer L; Hemminki K; Goldin LR; Travis LB
Int J Cancer; 2007 Mar; 120(5):1099-102. PubMed ID: 17131330
[TBL] [Abstract][Full Text] [Related]
50. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas.
Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ
Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822
[TBL] [Abstract][Full Text] [Related]
51. Clinical characteristics of familial vs. sporadic non-Hodgkin lymphoma in patients diagnosed at the Mayo Clinic (1986-2000).
Vachon CM; Habermann TM; Kurtin PJ; Cerhan JR
Leuk Lymphoma; 2004 May; 45(5):929-35. PubMed ID: 15291351
[TBL] [Abstract][Full Text] [Related]
52. Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011.
Al-Hamadani M; Habermann TM; Cerhan JR; Macon WR; Maurer MJ; Go RS
Am J Hematol; 2015 Sep; 90(9):790-5. PubMed ID: 26096944
[TBL] [Abstract][Full Text] [Related]
53. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Willis CR; Goodrich A; Park K; Waselenko JK; Lucas M; Reese A; Diehl LF; Grever MR; Byrd JC; Flinn IW
Ann Hematol; 2006 May; 85(5):301-7. PubMed ID: 16518606
[TBL] [Abstract][Full Text] [Related]
54. Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.
Drozd-Sokołowska J; Zaucha JM; Żółtak T; Jamroziak K; Grzybowska-Izydorczyk O; Witkowska M; Waszczuk-Gajda A; Kaźmierczak M; Szczepaniak A; Subocz E; Knopińska-Posłuszny W; Hołojda J; Kopińska A; Hus I; Rybka J; Wołowiec D; Kwiatkowski J; Hałaburda K; Smolewski P; Giebel S; Wiktor-Jędrzejczak W
Hematol Oncol; 2019 Oct; 37(4):383-391. PubMed ID: 31026087
[TBL] [Abstract][Full Text] [Related]
55. Periodontal disease and risk of non-Hodgkin lymphoma in the Health Professionals Follow-Up Study.
Bertrand KA; Shingala J; Evens A; Birmann BM; Giovannucci E; Michaud DS
Int J Cancer; 2017 Mar; 140(5):1020-1026. PubMed ID: 27861844
[TBL] [Abstract][Full Text] [Related]
56. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
[TBL] [Abstract][Full Text] [Related]
57. Soft tissue sarcoma, non-Hodgkin's lymphoma and chronic lymphocytic leukaemia in workers exposed to phenoxy herbicides: extended follow-up of a UK cohort.
Coggon D; Ntani G; Harris EC; Jayakody N; Palmer KT
Occup Environ Med; 2015 Jun; 72(6):435-41. PubMed ID: 25694496
[TBL] [Abstract][Full Text] [Related]
58. Association between Bacillus Calmette-Guérin vaccination and lymphoma: a population-based birth cohort study.
Salmon C; Conus F; Parent MÉ; Benedetti A; Rousseau MC
J Intern Med; 2019 Nov; 286(5):583-595. PubMed ID: 31361936
[TBL] [Abstract][Full Text] [Related]
59. Season of birth and risk of Hodgkin and non-Hodgkin lymphoma.
Crump C; Sundquist J; Sieh W; Winkleby MA; Sundquist K
Int J Cancer; 2014 Dec; 135(11):2735-9. PubMed ID: 24752499
[TBL] [Abstract][Full Text] [Related]
60. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
